ReWalk Robotics (NSDQ:RWLK) reported third-quarter results that came up shy of the consensus forecast. The Yokneam Illit, Israel–based robotic walking assistance company posted losses of -$3.4 million, or -46¢ per share, on sales of $1.2 million for the three months ended Sept. 30, for a 25.2% bottom-line gain on sales decline of -23.7%. Adjusted to exclude […]
Biolase beats Street despite Q3 losses
Biolase (NSDQ:BIOL) shares hit a slight uptick on third-quarter results that topped the consensus forecast in spite of revenue and profit dips. The Irvine, Calif.-based laser system developer earlier this month posted losses of -$5.5 million, or -25¢ per share, on sales of $8.6 million for the three months ended Sept. 30, for a 17.4% bottom-line […]
Myomo slides on missed Q3 projections
Myomo (NYSE:MYO) shares plummeted today on third-quarter sales shortcomings and a bottom-line dip. The Cambridge, Mass.–based wearable medical robotics company posted losses of -$2.8 million, or -16¢ per share, on sales of $606,619 for the three months ended Sept. 30, for a 5.2% bottom-line slide on a sales decline of 0.4%. Adjusted to exclude one-time […]
TransEnterix slashes workforce amid disappointing Q3 results
TransEnterix (NYSE:TRXC) has let go of 39 employees, 18% of its headcount, as the robot-assisted surgery company turns its focus on existing Sehance system customers versus drumming up sales. “Our key areas of focus in 2020 will be on market develop activities, expanding the clinical economic evidence, supporting Senhance and adding important new features, such as […]
Ocular Therapeutix dips on Q3 losses
Ocular Therapeutix (NSDQ:OCUL) shares fell today on third-quarter results that narrowly topped the consensus forecast despite a bottom-line dip. The Bedford, Mass.–based ophthalmic insert maker posted losses of -$18,778, or -45¢ per share, on sales of $829,000 for the three months ended Sept. 30, for a 25.1% bottom-line slide on sales growth of 66.5%. Adjusted to […]
Sientra posts Q3 losses, acquires Opus breast implant operation
Sientra (NSDQ:SIEN) shares skyrocketed today after the company posted Street-beating third-quarter results despite a bottom-line dip. The Santa Barbara, Calif.-based company is also acquiring the Opus breast implant manufacturing operation. Sientra posted losses of -$22.43 million, or -45¢ per share, on sales of $22.41 for the three months ended Sept. 30, for a 9.2% bottom-line slide […]
Dentsply Sirona raises guidance as Q3 earnings beat The Street
Dentsply Sirona (NSDQ:XRAY) shares are up today on third-quarter results that topped the consensus forecast. The York, Pa.–based dental equipment maker posted profits of $85 million, or 38¢ per share, on sales of $962.1 million for the three months ended Sept. 30, tripling its bottom line from the same quarter last year on sales growth of […]
Endologix rises after posting improved Q3 earnings
Endologix (NSDQ:ELGX) shares are up today on third-quarter results that improved from the same quarter last year and topped the consensus forecast. The Irvine, Calif.-based AFX stent graft developer posted losses of -$7.8 million, or -40¢ per share, on sales of 35.8 million for the three months ended Sept. 30, for a 23.2% bottom-line gain on […]
Glaukos slides on Q3 profit drop
Glaukos (NYSE:GKOS) shares dropped today on third-quarter earnings that topped the consensus forecast despite sliding profits. The San Clemente, Calif.-based ophthalmic medical technology and pharmaceutical company posted losses of -$13.5 million, or -37¢ per share, on sales of $58.5 million for the three months ended Sept. 30, for a large bottom-line slide on sales growth of […]
NATUS misses Q3 expectations on The Street
Natus Medical (NSDQ:NTUS) recently reported third-quarter numbers that missed expectations on earnings and sales. The Pleasanton, Calif.-based company continued in the black for the three months ended Sept. 30, posting profits of $8.5 million, or 25¢ per share, on sales of $123.5 million, a -5.4% top-line slip. Adjusted to exclude one-time items, earnings per share were […]
Dexcom jumps after hours on Q3 Street-beating earnings
Dexcom (NSDQ:DXCM) shares jumped after hours today on third-quarter results that bettered the consensus forecast. The San Diego–based continuous glucose monitoring system developer posted profits of $45.8 million, or 50¢ per share, on sales of $396.3 million for the three months ended Sept. 30, for a 1.7% bottom-line slide on sales growth of 48.6%. Adjusted to […]
- 1
- 2
- 3
- …
- 227
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube